Skip to main content
TipRanks
Go Ultimate75% OFF

Guard Therapeutics International AB (5LH0) Income Statement

1 Followers

Guard Therapeutics International AB Income Statement

Last quarter (Q1 2026), Guard Therapeutics International AB's total revenue was kr0.00. In Q1, Guard Therapeutics International AB's net income was kr-6.35M. See Guard Therapeutics International AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
kr 0.00kr 0.00kr -15.00Kkr -15.00Kkr -15.00K
kr 107.74Mkr 99.91Mkr 115.07Mkr 113.63Mkr 81.28M
Depreciation and Amortizationkr 0.00kr 15.00Kkr 15.00Kkr 15.00Kkr 15.00K
kr -107.74Mkr -100.23Mkr -114.91Mkr -112.82Mkr -82.01M
kr -107.74Mkr -99.91Mkr -115.07Mkr -114.92Mkr -81.90M
kr -1.11Mkr 3.84Mkr 1.75Mkr 2.08Mkr -130.00K
kr -108.85Mkr -96.07Mkr -113.32Mkr -112.84Mkr -82.03M
kr -108.85Mkr -96.07Mkr -113.32Mkr -110.76Mkr -82.16M
Per Share Metrics
Basic EPSkr -6.04kr -8.62kr -11.26kr -15.72kr -0.74
Diluted EPSkr -6.04kr -8.62kr -11.26kr -15.72kr -0.74
Weighted Average Shares Outstanding18.03M11.15M10.06M7.05M110.30M
Weighted Average Shares Outstanding (Diluted)18.03M11.15M10.06M7.05M110.30M

Currency in SEK

Guard Therapeutics International AB Earnings and Revenue History

-120M-80M-40M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin